Emily S.

Emily S. has extensive work experience spanning over two decades. Emily currently holds the position of Vice President, Head of CMC at PureTech Health since May 2021. Prior to that, they worked at Alexion Pharmaceuticals, Inc. from January 2018 to March 2021 as the Sr. Director, Clinical Manufacturing.

Before joining Alexion Pharmaceuticals, Emily held various roles at Celgene from 2006 to 2017. Emily served as the Director of Commercial Biologics Manufacturing from January 2016 to December 2017 and as the Director of Business Development & Global Alliances from February 2013 to January 2016, amongst other positions.

Their earlier experiences include working at Pfizer from 2004 to 2006 and at Pfizer (Wyeth Biopharma) from 2002 to 2004. Emily also worked at Emisphere Technologies, BASF (Engelhard Corporation), University of Virginia, and MillerCoors (Coors Brewing Company) in various engineering and research roles.

Overall, Emily has a strong background in biopharmaceutical manufacturing, business development, and research, which has contributed to their career growth and expertise in the industry.

Emily S. obtained a Bachelor of Science degree in Chemical Engineering from the University of Virginia, where they studied from 1995 to 1999.